Sepsis and signal transduction pathway: cross-talk TLR4/ MyD88/TRIF

doi: 10.18081/ajbm/2333-5106/014-04/150-163     
American Journal of BioMedicine Volume 3, Issue 4, pages 150-163
Published: 09 April 2015

Lothar Rink; Takashi Hebel; Jimmy Fukumoto


Sepsis is a consequence of infection that is difficult to predict, diagnose, and treat. Patients who develop sepsis have an increased risk of complications and death and face higher healthcare costs and longer treatment. LPS/TLR4 signaling has been intensively studied in the past few years. Still, it is poorly understood how the TLR-induced inflammatory and antiviral immune responses are balanced. Further, it’s unclear to identified molecules specifically involved in TLR signaling, where it differentially regulates MyD88 and TRIF signaling. Here we review molecules involved in TLR4-mediated signaling, including MyD88/TRIF pathway.

Keywords: Sepsis; LPS; MyD88; Proinflammatroy cytokines

Limited Access             Full Text-PDF                Cited-by-Linking


1. Rispens E, Bron A, Lee J, Fukumoto J. The pathophysiology of inflammation in cell injury. Pathophysiology of Cell Injury Journal 2014; 2:1-9. [Abstract/Full-Text]

2. Slimani H, Zhai Y, Yousif NG. Enhanced monocyte chemoattractant protein-1 production in aging mice exaggerates cardiac depression during endotoxemia. Crit Care 2014;18: 527. [Abstract/Full-Text]

3. O'Neill L A. How Toll-like receptors signal: what we know and what we don’t know. Curr Opin Immunol 2006;18:3–9. [PubMed]

4. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol. 2006;117:979–987. [PubMed]

5. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675-680. [PubMed]

6. Burns K, Martinon F, Esslinger C, et al. MyD88, an adaptor protein involved in IL-1 signaling. J Biol Chem 1998;273:12203–12209. [PubMed]

7. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999;11:115–122. [PubMed]

8. Ao L, Song Y, Fullerton DA, Dinarello CA, Meng X. The interaction between myocardial depressant factors in endotoxemic cardiac dysfunction: role of TNF-alpha in TLR4-mediated ICAM-1 expression. Cytokine 2007; 38:124-129. [PubMed]

9. Binck BW, Tsen MF, Islas M,  et al. Bone marrow-derived cells contribute to contractile dysfunction in endotoxic shock. Am J Physiol Heart Circ Physiol 2005;288:H577–H583. [PubMed]

10. Foley J, Aryal A, Yan L, Bell C, Tae-Young C. Brain cell injury following cerebral ischemia and reperfusion: positive effects of ICAM-1/ neuroprotective role of Taurine. Pathophysiology of Cell Injury Journal 2014; 2:10-21. [Abstract/Full-Text]

11. Yousif NG, Al-amran FG. Novel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin) induced cardiac injury in mice. BMC cardiovascular disorders 2011;11(1):62. [Abstract/Full-Text]

12. Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide–evidence for TLR4 as the Lps gene product. J Immunol 1999;162:3749-3752. [PubMed]

13. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4(7):499-511. [PubMed]

14. Yousif NG, Ao L, Li J, Aly A, Austin E, et al. Myocardial tissue TLR4 plays a major role in mediating myocardial injury following cold ischemia and reperfusion through up-regulation of MCP-1. Journal of Surgical Research 2011;165(2):181. [Abstract]

15. Adib-Conquy M, Adrie C, Moine P, et al. NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am J Respir Crit Care Med 2000;162:1877-1883. [PubMed]

16. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009;30:475-487. [PubMed]

17. Biswas SK, Tergaonkar V. Myeloid differentiation factor 88-independent Toll-like receptor pathway: sustaining inflammation or promoting tolerance? Int J Biochem Cell Biol 2007;39:1582-1592. [PubMed]

18. Ziegler-Heitbrock L. The p50-homodimer mechanism in tolerance to LPS. J Endotoxin Res 2001;7:219-222. [PubMed]

19. Wang Y, Tang Y, Teng L, Wu Y, Zhao X, Pei G. Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 2006;7:139-147. [PubMed]

20. Takeuchi O, Sato S, Horiuchi T, et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002;169:10-14. [PubMed]

Print Friendly, PDF & Email